Trademark Overview
On Tuesday, May 5, 2026, a trademark application was filed for OPROVDA with the United States Patent and Trademark Office. The USPTO has given the OPROVDA trademark a serial number of 99804604. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, June 25, 2026. This trademark is owned by Pfizer Inc.. The OPROVDA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorder; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; Pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
